Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,095 | 173,063 | 95,823 | 56,221 | 45,586 |
| Marketable Securities | 9,711 | 64,698 | 41,966 | 44,556 | 44,779 |
| Receivables | 33,082 | 20,302 | 15,443 | 12,704 | 11,717 |
| Inventories | 16,464 | 9,227 | 5,673 | 4,325 | 4,832 |
| TOTAL | $186,024 | $276,135 | $169,186 | $128,907 | $114,390 |
| Non-Current Assets | |||||
| PPE Net | 637 | 655 | 689 | 1,297 | 1,967 |
| Investments And Advances | 0 | 5,022 | 4,502 | 0 | 675 |
| Other Non-Current Assets | 13,794 | 3,899 | 3,934 | 5,415 | 2,714 |
| TOTAL | $14,431 | $9,576 | $9,125 | $6,712 | $5,356 |
| Total Assets | $200,455 | $285,711 | $178,311 | $135,619 | $119,746 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 27,717 | 27,431 | 16,538 | 12,383 | 12,102 |
| Accrued Expenses | 13,516 | 10,570 | 10,814 | 8,257 | 6,948 |
| Other current liabilities | 5,185 | 7,948 | 3,860 | 3,276 | 3,330 |
| TOTAL | $46,418 | $45,949 | $31,212 | $23,916 | $22,380 |
| Non-Current Liabilities | |||||
| Long Term Debt | 122,210 | 121,734 | 98,551 | 97,537 | N/A |
| Other Non-Current Liabilities | 137,301 | 126,831 | 113,760 | 103,527 | 88,953 |
| TOTAL | $259,511 | $248,565 | $212,311 | $201,064 | $88,953 |
| Total Liabilities | $305,929 | $294,514 | $243,523 | $224,980 | $111,333 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 46,094 | 34,122 | 23,441 | 22,668 |
| Common Shares | 133 | 115 | 89 | 63 | 61 |
| Retained earnings | -959,716 | -806,222 | -679,348 | -577,104 | -467,321 |
| Other shareholders' equity | 19 | 56 | 12 | -107 | -25 |
| TOTAL | $-105,474 | $-8,803 | $-65,212 | $-89,361 | $8,413 |
| Total Liabilities And Equity | $200,455 | $285,711 | $178,311 | $135,619 | $119,746 |